Skip to content

Prospective Study of Altis System With the TVTO Procedure for the Management of Stress Urinary Incontinence in Women

Prospective Randomized Trial of Altis Minisling With the TVTO Transobturator Tape Procedure for the Management of Genuine Stress Urinaty Incontinence in Women

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03515109
Enrollment
40
Registered
2018-05-03
Start date
2017-11-25
Completion date
2018-11-25
Last updated
2018-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genuine Stress Incontinence

Keywords

stress incontinence, female, altis, transobturator tape, minisling

Brief summary

Prospective randomized comparison of minisling (altis) with the TVTO procedure for the management of women with genuine stress urinary incontinence.

Detailed description

Prospective randomized study double blinded. Two group of patients consisting group A of 40 patients being operated with altis minisling and group B with 40 patients operated with TVTO procedure. All patients will be operated with epidural anesthesia. The patients participating in the study will meet the following requirements. a. Having genuine stress urinary incontinence proven by urodynamics, b. be willing to be operated and participate in the study. Exclusion criteria wil be the following: a.History of previous irradiation in the lower genital tract, b. BMI more than 30kg/m2, c.previous anti-incontinence surgery, previous vaginal surgery, e. having MUCP\< 20 cm H2O or Valsava leak point pressure less than than 60 cm H2O. Patients will be allocated in each operation by an automatic system using a computer software. Primary outcome measure will be the objective cure rate at 6 months as it is assessed with cough stress test during urodynamics. Secondary outcome measures will be the subjective cure rate, improvement and failure rate, the incidence of complications such as obstruction, voiding difficulties, hemorrhage etc. Patients will be asked to complete preoperatively and postoperatively the ICIQ-FLUTS, patient satisfaction questionnaire and the female sexual function index.postoperatively the patients will complete the PGI-I questionnaire.

Interventions

PROCEDUREAltis tape

placement of Altis tape through transobturator foramen bilaterally under epidural anesthesia

PROCEDURETVTO

placement of TVTO tape through transobturator foarmen bilaterally under epidural anesthesia

Sponsors

Aretaieio Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Masking description

they will not be aware of the procedure they are going to perform or have.

Intervention model description

prospective randomised

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

Inclusin Criteria: * Having genuine stress urinary incontinence proven by urodynamics * be willing to be operated and participate in the study.

Exclusion criteria

* History of previous irradiation in the lower genital tract * BMI more than 30kg/m2 * previous anti-incontinence surgery, previous vaginal surgery * having MUCP\< 30 cm H2O or Valsava leak point pressure less than than 60 cm H2O * Mixed urinary incontinence.

Design outcomes

Primary

MeasureTime frameDescription
the objective urinary continence rate at 12 months1 yearPrimary outcome measure will be the objective urinary continence rate at 12 months as it is assessed with cough stress test during urodynamics.

Secondary

MeasureTime frameDescription
Subjective urinary continence rate at 12 months follow up1yearSecondary outcome measure will be the subjective continence rate as it is assessed with the use of the PGI-I questionnaire.
Preoperative and postoperative assessment of sexual function1 yearPatients will be asked to complete preoperatively and postoperatively the female sexual function index. Minimum score 2.0 and maximum score 36.0. Higher values represent a better outcome.

Countries

Greece

Contacts

Primary ContactPANAGIOTIS VAKAS
P_BAKAS@YAHOO.COM2107473204
Backup ContactEmmanouil papadakis, Dr
papadakisemm2@gmail.com6944864531

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026